cerrar
Tagged with Regulation

Interview: Éric Gervais, Executive Vice President, Médunik…
As the only country in the G8 without an orphan drugs act, the president of Médunik, a company focused on bringing orphan drugs into the country,…

Interview: Sybil Dahan, President, Triton Pharma, Canada
An interesting perspective on the Canadian market, and its opportunities and challenges in drug registration on a regional level from the President of…

Interview: Calvin Tsai CEO of Orient Pharma & Jack Wu,…
Calvin Tsai and Jack Wu talk about their two-pronged international approach through pharmaceuticals and nutricare. The head of the nutricare business…

Interview: Paul Glover, Associate Deputy Minister, Health Canada
A perspective from Canada’s national health body on the future of medicine in the 21st century, from the shift to personalized medicine to…

Interview: Jon Fairest, President & CEO, Sanofi Canada
The President & CEO of Sanofi Canada talks candidly about the pros and cons of the current administrative setup of the Canadian healthcare…

Colombia’s Law 100: from 93 to infinity?
President Santos appointed economist Alejandro Gaviria as the new Minister of Health and Social Protection in September 2012. Gaviria‰Ûªs priority…

Interview: Tom Rönnlund, General Manager Nordic & Baltic…
Tom Rönnlund discusses the current state of the pharmaceutical industry in the Nordics in this time of austerity, and offers opinions on reference…

Interview: Else Smith, Director General, CEO, The Danish Health…
After the big milestone last year— the Danish Medicines Agency merging with the Danish National Board of Health— can you please comment on why…

Interview with Carlos Espíndola-Scapetta, Senior Partner,…
An expert in trade and regulatory issues relating to the pharmaceutical industry in Colombia, the senior partner of Espíndola International…

Interview: Peter Erlbacher, Chief Operations Officer, Spanish…
The Aspen Group identified Latin America as a “large developing market where it can leverage its substantial intellectual property portfolio and…

Interview: Satish Reddy, Managing Director and Chief Operating…
Looking back at the company’s recent challenges, we see a very tough 2009, largely due to the Betapharm acquisition and the subsequent changes in…

Interview: Satish Reddy, Managing Director and Chief Operating…
Looking back at the company’s recent challenges, we see a very tough 2009, largely due to the Betapharm acquisition and the subsequent changes in…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here